|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Methotrexate-related pulmonary complications in rheumatoid arthritis显示文摘 | Barrera P Laan R F Van Riel P L | 1994 | Ann Rheum Dis1994，53，7： | 1 |
| 2 | Burden of disease in treated rheumatoid arthritis patients: going beyond the joint 显示文摘 | CUTOLO M KITAS G D VAN RIEL P L | 2014 | Semin Arthritis Rheum2014，43，4： | 1 |
| 3 | The role of TNF- alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk显示文摘 | Popa C Netea M G Van Riel P L | 2007 | J Lipid Res2007，48，4： | 1 |
| 4 | Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis显示文摘 | van Riel P L Nuver-Zwart I H | 1989 | Lancet1989，1，8646： | 1 |
| 5 | The Disease Activity Score and the EULAR criteria显示文摘 | Fransen J van Riel P L | 2005 | Clin Exp Rheumatol2005，23，539： | 1 |
| 6 | The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk显示文摘 | Popa C Netea M G van Riel P L | 2007 | J Lipid Res2007，48，4： | 1 |
| 7 | An interlaboratory comparison of physiological and geneticproperties of four Saccharomyces cerevisiae strains 显示文摘 | van Dijken J P Bauer J Brambilla L Duboc P Francois J M Gancedo C Giuseppin M L Heijnen J J Hoare M Lange H C Madden E A Niederberger P Nielsen J Parrou J L Petit T Porro D Reuss M van Riel N Rizzi M Steensma H Y Verrips C T Vindelov J Pronk J T | 2000 | Enzyme Microbiology Technology2000，26，： | 1 |
| 8 | Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis 显示文摘 | Van der Heijde D M van Riel P L Nuver-Zwart I H | 1989 | Lancet1989，1，8646： | 1 |
| 9 | The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk显示文摘 | Popa C Netea M G Van Riel P L C M | 2007 | J Lipid Res2007，48，4： | 1 |
| 10 | The role of TNF-alpha in chronic inflammatory conditions, inter- mediary metabolism, and cardiovascular risk 显示文摘 | POPA C NETEA M G VAN RIEL P L | 2007 | J Lipid Res2007，48，4： | 1 |
| 11 | How does one assess early rheumatoid arthritis in daily clinical practice? 显示文摘 | Van Riel P L Schumacher H R Jr | 2011 | Best Pract Res Clin Rheumatol2011，15，1： | 1 |
| 12 | 泼尼松龙能否作为痛风急性发作期的一线治疗药物?显示文摘读者来信
Janssens及其同事发表的随机试验(本刊2卷9期“论文摘要”)结果表明,泼尼松龙和萘普生在治疗痛风急性发作时具有相同疗效;而且提示皮质类固醇激素比秋水仙碱或非同醇类抗炎药(NSAID)更安全,并由此推论,试验结果为泼尼松龙作为痛风患者的一线治疗药物提供了强有力的证据。 | HJJanssens M Jonssen EH van de Lisdonk P L van Riel C van Weef | 2009 | 世界临床医学2009，，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员